You can buy or sell Valeritas and other stocks, options, ETFs, and crypto commission-free!
Valeritas Holdings, Inc. Common Stock, also called Valeritas, is a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with diabetes. Read More It offers products under the V-Go brand. V-Go Disposable Insulin Delivery Device, is used by patients with type 2 diabetes to maintain target blood glucose goals. The firm's single-use disposable V-Go device includes V-Go PreFill and V-Go Link. The company was founded by Leisa Swanson and Robert R. Gonnelli on May 9, 2014 and is headquartered in Bridgewater, NJ.
Bridgewater, New Jersey
52 Week High
52 Week Low
Seeking AlphaMar 6
Valeritas Holdings, Inc. 2018 Q4 - Results - Earnings Call Slides
The following slide deck was published by Valeritas Holdings, Inc. in conjunction with their 2018 Q4 earnings call. 1 21 Click to enlarge Notes:...
Seeking AlphaMar 5
Valeritas Holdings, Inc. (VLRX) CEO John Timberlake on Q4 2018 Results - Earnings Call Transcript
Valeritas Holdings, Inc. (NASDAQ:VLRX) Q4 2018 Results Conference Call March 4, 2019 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group John Timberlake - President and Chief Executive Officer Erick Lucera - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Marie Thibault - BTIG Operator Welcome to Valeritas Fourth Quarter Financial Results Conference Call [Operator Instructions]. As a reminder, this conference call is being recorded today March 5, 201...
Expected May 9, After Hours